ArticleFrontiers in microbiology2026

Commentary: CRISPR-Cas systems against carbapenem resistance-from proof-of-concept to clinical translation.

Jayarajan D et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.